1-2 of 2
Robert F Ott, MBA
Close
Sort by
Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Kristen Detweiler-Short, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Terri L. Jobkar, BSN, Diane E Durecki, BA, Sandra M. Wear, RN, Robert F Ott, MBA, Ammar Al-Zoubi, MD, Melissa A Mietzel, M.S. CCRP, M Hussein, Daniel Couriel, MD, Joseph A Leveque, MD, Ravi Vij, MD
Journal: Blood
Blood (2011) 118 (21): 631.
https://doi.org/10.1182/blood.V118.21.631.631
Published: 2011
Journal Articles

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Sandra M. Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MD, Mark Fiala, BS, Sagar Lonial, MD, Alaina R. Mitchell, BS, David S. Siegel, MD, PhD, Adolfo Aleman, CCRP, Andrzej J Jakubowiak, MD, PhD, Diane E Durecki, BA, Donna E. Reece, MD, FRCPC, Engin Gul, HonBSc, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Mindy A Bowers, BS, A. Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Geraldine Pelle-Day, Ph.D., Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Daniel Larsen, BS, Shaji Kumar, MD, Ann Birgin, CRA, Noopur S. Raje, MD, Vivek Roy, M.D., Michele Maharaj, RN, Joseph W. Fay, MD, Tracey Messing, RN, Robert F Ott, MBA, Leah Tasca, BA, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2011) 118 (21): 1024.
https://doi.org/10.1182/blood.V118.21.1024.1024
Published: 2011